AMLX
Price
$14.49
Change
+$0.02 (+0.14%)
Updated
Feb 3 closing price
Capitalization
1.59B
56 days until earnings call
Intraday BUY SELL Signals
HROW
Price
$47.19
Change
+$6.62 (+16.32%)
Updated
Feb 3 closing price
Capitalization
1.75B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs HROW

Header iconAMLX vs HROW Comparison
Open Charts AMLX vs HROWBanner chart's image
Amylyx Pharmaceuticals
Price$14.49
Change+$0.02 (+0.14%)
Volume$1.41M
Capitalization1.59B
Harrow
Price$47.19
Change+$6.62 (+16.32%)
Volume$682.25K
Capitalization1.75B
AMLX vs HROW Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
HROW
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMLX vs. HROW commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and HROW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (AMLX: $14.49 vs. HROW: $47.19)
Brand notoriety: AMLX and HROW are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 83% vs. HROW: 117%
Market capitalization -- AMLX: $1.59B vs. HROW: $1.75B
AMLX [@Pharmaceuticals: Generic] is valued at $1.59B. HROW’s [@Pharmaceuticals: Generic] market capitalization is $1.75B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • HROW’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 6 bearish.
  • HROW’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HROW is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а -6.33% price change this week, while HROW (@Pharmaceuticals: Generic) price change was +9.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.87%. For the same industry, the average monthly price growth was -0.69%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

HROW is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($1.75B) has a higher market cap than AMLX($1.59B). AMLX YTD gains are higher at: 19.950 vs. HROW (-3.694). HROW has higher annual earnings (EBITDA): 39.4M vs. AMLX (-156.76M). AMLX has more cash in the bank: 344M vs. HROW (74.3M). AMLX has less debt than HROW: AMLX (5.94M) vs HROW (252M). HROW has higher revenues than AMLX: HROW (250M) vs AMLX (-665K).
AMLXHROWAMLX / HROW
Capitalization1.59B1.75B91%
EBITDA-156.76M39.4M-398%
Gain YTD19.950-3.694-540%
P/E Ratio2.69N/A-
Revenue-665K250M-0%
Total Cash344M74.3M463%
Total Debt5.94M252M2%
FUNDAMENTALS RATINGS
HROW: Fundamental Ratings
HROW
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXHROW
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
HROW
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSCCX20.910.07
+0.34%
Invesco Main Street Small Cap C
EPSRX25.670.07
+0.27%
NYLI Epoch Global Equity Yield Class R6
DBOZX24.61-0.09
-0.36%
BNY Mellon Balanced Opportunity Z
PLFMX32.81-0.28
-0.85%
Principal Large Cap S&P 500 Index R3
MLMAX23.96-0.29
-1.20%
Morgan Stanley Instl Global Core A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.23%
XOMAO - AMLX
68%
Closely correlated
-0.39%
XOMAP - AMLX
51%
Loosely correlated
+1.00%
OCUL - AMLX
46%
Loosely correlated
-6.99%
LRMR - AMLX
45%
Loosely correlated
-1.71%
RGNX - AMLX
43%
Loosely correlated
+0.74%
More

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with TKNO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then TKNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+5.10%
TKNO - HROW
35%
Loosely correlated
+2.95%
AMRX - HROW
34%
Loosely correlated
+0.42%
AMLX - HROW
33%
Loosely correlated
-1.23%
VTRS - HROW
32%
Poorly correlated
N/A
AQST - HROW
29%
Poorly correlated
N/A
More